# Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

> **NCT03991936** · PHASE4 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 11 (actual)

## Conditions studied

- Nail Psoriasis
- Nail Diseases

## Interventions

- **DRUG:** Placebos
- **DRUG:** Triamcinolone Acetonide 2.5 mg/mL
- **DRUG:** Triamcinolone Acetonide 5.0 mg/mL
- **DRUG:** Triamcinolone Acetonide 7.5 mg/mL
- **DRUG:** Triamcinolone Acetonide 10 mg/mL

## Key facts

- **NCT ID:** NCT03991936
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-11
- **Primary completion:** 2023-03-29
- **Final completion:** 2023-03-29
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03991936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03991936, "Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03991936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*